TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
ELAN

Elanco Animal Health

Healthcare · Drug Manufacturers - Specialty & Generic

22.50$ +1.7% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow ELAN
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +2,262.1% +11.5% +180.4% -54.0% -118.3% – -6.4% -40.0% +99.6% +3.5%
– +7.4% +25.2% -7.0% +6.3% +64.4% +38.5% -4.7% +1.8% -4.6% +2.7%
– +52.2% +22.5% +4.0% +90.0% -4.9% +40.4% -10.6% -22.0% +19.6% +23.6%
– – -5.2% -88.0% +172.6% -857.3% – -93.3% – – –
– – – -154.6% – – -151.5% – – – -33.6%
– +10.2% -10.6% +36.4% +46.8% +57.5% -36.6% -6.6% -16.3% -4.5% +87.8%
– -96.4% +429.7% -86.8% +84.9% +1,935.4% -88.9% -66.2% -5.6% – -124.1%
– – – – – – – – – – –
– +0.0% +0.0% -1.0% -104.9% – -93.6% -314.9% -85.1% +1,815.6% -61.8%
– -102.8% – -104.2% +765.9% – -95.8% -361.4% -84.9% +1,697.6% -81.6%
– -158.6% – +448.1% -193.9% – -17.7% -322.0% – +1,557.1% -33.6%
– – +64.9% +369.1% -92.4% -1,418.0% – -6.3% -56.3% +236.8% -27.9%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?